Mark R. Ziebell
2018
In 2018, Mark R. Ziebell earned a total compensation of $409.5K as Vice President, General Counsel and Corporate Secretary at Peregrine Pharmaceuticals, a 30% decrease compared to previous year.
Compensation breakdown
| Salary | $361,920 |
|---|---|
| Other | $47,564 |
| Total | $409,484 |
Ziebell received $361.9K in salary, accounting for 88% of the total pay in 2018.
Ziebell also received $47.6K in other compensation.
Rankings
In 2018, Mark R. Ziebell's compensation ranked 12,466th out of 14,244 executives tracked by ExecPay. In other words, Ziebell earned more than 12.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,466 out of 14,244 | 13th |
Division Manufacturing | 5,050 out of 5,765 | 12th |
Major group Chemicals And Allied Products | 1,918 out of 2,128 | 10th |
Industry group Drugs | 1,642 out of 1,817 | 10th |
Industry Pharmaceutical Preparations | 1,258 out of 1,391 | 10th |
Source: SEC filing on August 17, 2018.
Ziebell's colleagues
We found four more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2018.
2018
Roger Lias
Peregrine Pharmaceuticals
Chief Executive Officer
2018
Steven King
Peregrine Pharmaceuticals
Chief Executive Officer
2018
Joseph Shan
Peregrine Pharmaceuticals
Former Vice President, Clinical & Regulatory Affairs
2018
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
News
Peregrine Pharmaceuticals CEO Nicholas Green's 2023 pay rises 5% to $6.5M
August 28, 2023
Peregrine Pharmaceuticals CEO Nicholas Green's 2022 pay jumps 117% to $6.2M
August 29, 2022
Peregrine Pharmaceuticals CEO Nicholas Green receives $2.8M in 2021
August 27, 2021
Peregrine Pharmaceuticals General Counsel Mark Ziebell's 2020 pay jumps 124% to $1.1M
August 27, 2020
Peregrine Pharmaceuticals CEO Roger Lias' 2019 pay jumps 25% to $880K
August 21, 2019
Peregrine Pharmaceuticals CEO Roger Lias receives $704K in 2018
August 17, 2018